In 1957, just four years after Francis Crick and other scientists solved the riddle of DNA’s structure—the now famous double helix—Crick laid out what he called the “central dogma” of molecular ...

Over the last few years, scientists and entrepreneurs have flocked to developing medicines that target RNA, the genetic blueprint that cells in our bodies use to make proteins. RNA has been in the ...

Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions. The new test analyzes ...

People are still debating whether the mRNA from COVID-19 vaccines remains in the body longer than it should. Some say it lingers and causes harm, others say that idea just doesn’t hold up. A new ...

It's no secret that we need new ways to treat and detect disease, including cancer. Specifically, we need better biomarkers that can be used for diagnosis and better ways to selectively get medicine ...

Two biotech leaders, John Maraganore and Clive Meanwell, are embarking on what Maraganore is calling their third act together: a new start-up called Corsera Health. Their first act together, as ...